Launch week offerEnds in00h00m00s
annual Promonthly Pro
Reina Armamento-Villareal
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
CYP19A1 Gene and Pharmacogenetics of Response to Testosterone Therapy
Open Date:
Close Date:
Grant: Close
Aromatase inhibitors and weight loss in severely obese men with hypogonadism
Open Date:
Close Date:
Grant: Close
Testosterone therapy and bone quality in men with type 2 diabetes and hypogonadism
Open Date:
Close Date:
Articles (5)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Skeletal fracture has recently emerged as a complication of obesity. Given the normal or better than normal bone mineral density (BMD), the skeletal fragility of these patients appears to be a problem of bone quality rather than quantity. Type 2 diabetes mellitus (T2DM), the incidence of which increases with increasing body mass index, is also associated with an increased risk for fractures despite a normal or high BMD. With the additional bone pathology from diabetes itself, patients with both obesity and T2DM could have a worse skeletal profile. Clinically, however, there are no available methods for identifying those who are at higher risk for fractures or preventing fractures in this subgroup of patients. Weight loss, which is the cornerstone in the management of obesity (with or without T2DM), is also associated with an increased risk of bone loss. This review of the literature will focus on the skeletal manifestations associated with obesity, its interrelationship with the bone defects associated with T2DM, and the available approach to the bone health of patients suffering from obesity.
Year:
2023
Collaborators (2)
Georgia Colleluori
Assistant Professor
Marche Polytechnic University
Fida Bacha
Professor of Pediatrics
Texas Children's Hospital
Make your next move.
Prepare your application
Review drafts before you send them.